Literature DB >> 5303324

The mechanism of the pyrogenic effect of streptococcus cell wall mucopeptide.

K Masek, H Rasková, J Rotta.   

Abstract

1. The intravenous injection into rabbits of 25-50 mug of a preparation of cell-wall mucopeptide (SM) from group A streptococcus produced a rise in rectal temperature and a fall in the number of circulating granulocytes in the blood.2. The pyrogenic response to SM is not dependent on the circulating granulocytes since it occurred also in rabbits made leucopenic by nitrogen mustard (HN 3).3. The pyrogenic response to SM was enhanced after an intravenous injection of 5-hydroxytryptophan (5-HTP).4. Pre-treatment with reserpine caused a much greater attenuation of the pyrogenic response to SM than pre-treatment with alpha-methyl-para-tyrosine (AMPT).5. As the reserpine reduced the 5-hydroxytryptamine (5-HT) and noradrenaline level in the hypothalamus, whereas the AMPT reduced only the noradrenaline level, it is concluded that 5-HT may be involved in the pyrogenic response and the way in which 5-HT may exert this function is discussed.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5303324      PMCID: PMC1365327          DOI: 10.1113/jphysiol.1968.sp008610

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  16 in total

1.  A NEW CONCEPT OF TEMPERATURE REGULATION BY AMINES IN THE HYPOTHALAMUS.

Authors:  W FELDBERG; R D MYERS
Journal:  Nature       Date:  1963-12-28       Impact factor: 49.962

2.  A SENSITIVE METHOD FOR SPECTROPHOTOFLUOROMETRIC ASSAY OF CATECHOLAMINES.

Authors:  C C CHANG
Journal:  Int J Neuropharmacol       Date:  1964-12

3.  [Control of experimental fever by reserpine and sympatholytics in guinea pigs].

Authors:  G KRONEBERG; H G KURBJUWEIT
Journal:  Arzneimittelforschung       Date:  1959-09

4.  Studies on the cause of fever.

Authors:  W B WOOD
Journal:  N Engl J Med       Date:  1958-05-22       Impact factor: 91.245

5.  Identification and assay of serotonin in brain.

Authors:  D F BOGDANSKI; A PLETSCHER; B B BRODIE; S UNDENFRIEND
Journal:  J Pharmacol Exp Ther       Date:  1956-05       Impact factor: 4.030

6.  Inhibition of endotoxin fever by reserpine.

Authors:  R Des Prez; R Helman; J A Oates
Journal:  Proc Soc Exp Biol Med       Date:  1966-07

7.  Effects of intraventricular and intrahypothalamic injection of noradrenaline and 5-HT on body temperature in conscious rabbits.

Authors:  K E Cooper; W I Cranston; A J Honour
Journal:  J Physiol       Date:  1965-12       Impact factor: 5.182

8.  Studies on the chemical structure of the streptococcal cell wall. I. The identification of a mucopeptide in the cell walls of groups A and A-variant streptococci.

Authors:  R M KRAUSE; M MCCARTY
Journal:  J Exp Med       Date:  1961-07-01       Impact factor: 14.307

9.  Endotoxin fever in granulocytopenic animals.

Authors:  J C HERION; R I WALKER; J G PALMER
Journal:  J Exp Med       Date:  1961-06-01       Impact factor: 14.307

10.  Studies on the pathogenesis of fever. XIV. Further observations on the chemistry of leukocytic pyrogen.

Authors:  G W Rafter; S F Cheuk; D W Krause; W B Wood
Journal:  J Exp Med       Date:  1966-03-01       Impact factor: 14.307

View more
  4 in total

1.  [Biological activity of bacterial peptidoglycan (mucopeptide) (author's transl)].

Authors:  B Heymer
Journal:  Klin Wochenschr       Date:  1975-01-15

2.  Pyrogen fever in rabbits pretreated with p-chlorophenylalanine or 5, 6-dihydroxytryptamine.

Authors:  M O Carruba; H P Bächtold
Journal:  Experientia       Date:  1976-06-15

3.  On the mechanism of fever caused by the mucopeptide of group A streptococcus.

Authors:  K Masek; H Rasková; J Rotta
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

4.  Changes of pharmacokinetics of trimethoprim after pretreatment with streptococcal peptidoglycan.

Authors:  J Lavický; J Cerný; L Celeda; J Rotta; J Kvĕtina; H Raśková; A Kubícek
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1986 Jan-Mar       Impact factor: 2.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.